Our editorial approach
We prioritize clarity about what is known and what remains uncertain. Our process brings together registry data, peer-reviewed literature summaries, and official safety guidance to form concise explanatory content without overstating conclusions. For details on broader service offerings connected to our work see our description of services at the services overview.
How we source and vet information
Content is assembled from primary literature, clinical registries, and recognized public health resources. When describing risks or regulatory frameworks we cross-check against authoritative sources such as the National Institutes of Health; for example, basic drug-safety references are aligned with entries on Wikipedia’s drug safety overview for readers seeking background context, and institutional guidelines like those at CDC where relevant.
Editorial checks
- Independence: We publish without financial conflicts affecting coverage.
- Evidence before claims: We link to primary sources and note strength and limits of evidence.
- Safety context: Potential harms and regulatory status are highlighted wherever material.
- Plain language: We aim for accessibility without sacrificing nuance.